These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9266357)

  • 21. Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.
    Jones SJ; Turano G; Kriss A; Shawkat F; Kendall B; Thompson AJ
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):260-5. PubMed ID: 7673953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain MRI changes in phenylketonuria. Associations with dietary status.
    Thompson AJ; Tillotson S; Smith I; Kendall B; Moore SG; Brenton DP
    Brain; 1993 Aug; 116 ( Pt 4)():811-21. PubMed ID: 8353710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.
    Bick U; Ullrich K; Stöber U; Möller H; Schuierer G; Ludolph AC; Oberwittler C; Weglage J; Wendel U
    Eur J Pediatr; 1993 Dec; 152(12):1012-20. PubMed ID: 8131802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
    Möller HE; Weglage J; Wiedermann D; Ullrich K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities.
    Brenton DP; Pietz J
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S114-20. PubMed ID: 11043157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine.
    Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H
    Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Congenital errors of metabolism: phenylketonuria and hyperphenylalanemias].
    Laguna Serrano C
    An R Acad Nac Med (Madr); 1982; 99(4):783-814. PubMed ID: 7185286
    [No Abstract]   [Full Text] [Related]  

  • 33. MR imaging-based volumetry in patients with early-treated phenylketonuria.
    Pfaendner NH; Reuner G; Pietz J; Jost G; Rating D; Magnotta VA; Mohr A; Kress B; Sartor K; Hähnel S
    AJNR Am J Neuroradiol; 2005 Aug; 26(7):1681-5. PubMed ID: 16091513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylketonuria: diffusion magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Sener RN
    J Comput Assist Tomogr; 2003; 27(4):541-3. PubMed ID: 12886140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unchanged MRI of myelin in adolescents with PKU supplied with non-phe essential amino acids after dietary relaxation.
    Lou HC; Toft PB; Andresen J; Mikkelsen I; Olsen B; Guldberg P; Güttler F
    Acta Paediatr; 1994 Dec; 83(12):1312-4. PubMed ID: 7734878
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.
    Leuzzi V; Trasimeni G; Gualdi GF; Antonozzi I
    J Inherit Metab Dis; 1995; 18(5):624-34. PubMed ID: 8598645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylketonuria: evidence-based clinical practice. Summary of the roundtable discussion.
    Burgard P; Link R; Schweitzer-Krantz S
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S163-8. PubMed ID: 11221745
    [No Abstract]   [Full Text] [Related]  

  • 40. A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria.
    Bodner KE; Aldridge K; Moffitt AJ; Peck D; White DA; Christ SE
    Mol Genet Metab; 2012 Nov; 107(3):302-7. PubMed ID: 23006929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.